vs
DLH Holdings Corp.（DLHC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是DLH Holdings Corp.的1.0倍（$69.8M vs $68.9M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -1.9%，领先386.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -24.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -17.4%）
DLH Holdings Corp.是一家总部位于美国的政府服务供应商，主要为退伍军人事务部、国防部、卫生与公众服务部等联邦机构提供技术赋能的医疗、物流、工程及任务支持服务，同时服务部分州及地方公共部门客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
DLHC vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.0倍
$68.9M
营收增速更快
RIGL
高出45.3%
-24.1%
净利率更高
RIGL
高出386.0%
-1.9%
两年增速更快
RIGL
近两年复合增速
-17.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $68.9M | $69.8M |
| 净利润 | $-1.3M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 2.1% | 33.2% |
| 净利率 | -1.9% | 384.0% |
| 营收同比 | -24.1% | 21.2% |
| 净利润同比 | -218.7% | 1769.2% |
| 每股收益（稀释后） | $-0.09 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DLHCRIGL
| Q4 25 | $68.9M | $69.8M | ||
| Q3 25 | $81.2M | $69.5M | ||
| Q2 25 | $83.3M | $101.7M | ||
| Q1 25 | $89.2M | $53.3M | ||
| Q4 24 | $90.8M | $57.6M | ||
| Q3 24 | $96.4M | $55.3M | ||
| Q2 24 | $100.7M | $36.8M | ||
| Q1 24 | $101.0M | $29.5M |
净利润DLHCRIGL
| Q4 25 | $-1.3M | $268.1M | ||
| Q3 25 | $-920.0K | $27.9M | ||
| Q2 25 | $289.0K | $59.6M | ||
| Q1 25 | $878.0K | $11.4M | ||
| Q4 24 | $1.1M | $14.3M | ||
| Q3 24 | $2.3M | $12.4M | ||
| Q2 24 | $1.1M | $-1.0M | ||
| Q1 24 | $1.8M | $-8.2M |
毛利率DLHCRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率DLHCRIGL
| Q4 25 | 2.1% | 33.2% | ||
| Q3 25 | 2.8% | 40.9% | ||
| Q2 25 | 4.5% | 60.1% | ||
| Q1 25 | 5.7% | 23.9% | ||
| Q4 24 | 6.2% | 28.9% | ||
| Q3 24 | 6.6% | 25.4% | ||
| Q2 24 | 5.7% | 1.2% | ||
| Q1 24 | 5.9% | -23.6% |
净利率DLHCRIGL
| Q4 25 | -1.9% | 384.0% | ||
| Q3 25 | -1.1% | 40.2% | ||
| Q2 25 | 0.3% | 58.6% | ||
| Q1 25 | 1.0% | 21.5% | ||
| Q4 24 | 1.2% | 24.9% | ||
| Q3 24 | 2.4% | 22.5% | ||
| Q2 24 | 1.1% | -2.8% | ||
| Q1 24 | 1.8% | -27.9% |
每股收益（稀释后）DLHCRIGL
| Q4 25 | $-0.09 | $14.11 | ||
| Q3 25 | $-0.07 | $1.46 | ||
| Q2 25 | $0.02 | $3.28 | ||
| Q1 25 | $0.06 | $0.63 | ||
| Q4 24 | $0.08 | $0.82 | ||
| Q3 24 | $0.16 | $0.70 | ||
| Q2 24 | $0.08 | $-0.06 | ||
| Q1 24 | $0.12 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.0K | $155.0M |
| 总债务越低越好 | $133.5M | $52.5M |
| 股东权益账面价值 | $112.2M | $391.5M |
| 总资产 | $283.5M | $513.6M |
| 负债/权益比越低杠杆越低 | 1.19× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DLHCRIGL
| Q4 25 | $257.0K | $155.0M | ||
| Q3 25 | $125.0K | $137.1M | ||
| Q2 25 | $194.0K | $108.4M | ||
| Q1 25 | $196.0K | $77.1M | ||
| Q4 24 | $451.0K | $77.3M | ||
| Q3 24 | $342.0K | $61.1M | ||
| Q2 24 | $423.0K | $49.1M | ||
| Q1 24 | $238.0K | $49.5M |
总债务DLHCRIGL
| Q4 25 | $133.5M | $52.5M | ||
| Q3 25 | $128.0M | $60.0M | ||
| Q2 25 | $138.3M | $60.0M | ||
| Q1 25 | $147.3M | $60.0M | ||
| Q4 24 | $162.2M | $60.0M | ||
| Q3 24 | $149.4M | $60.0M | ||
| Q2 24 | $160.9M | $60.0M | ||
| Q1 24 | $164.8M | $60.0M |
股东权益DLHCRIGL
| Q4 25 | $112.2M | $391.5M | ||
| Q3 25 | $113.0M | $117.6M | ||
| Q2 25 | $113.7M | $81.9M | ||
| Q1 25 | $112.8M | $18.6M | ||
| Q4 24 | $111.4M | $3.3M | ||
| Q3 24 | $110.1M | $-14.6M | ||
| Q2 24 | $108.6M | $-29.9M | ||
| Q1 24 | $106.8M | $-31.7M |
总资产DLHCRIGL
| Q4 25 | $283.5M | $513.6M | ||
| Q3 25 | $290.7M | $242.5M | ||
| Q2 25 | $299.3M | $206.7M | ||
| Q1 25 | $306.6M | $176.0M | ||
| Q4 24 | $325.0M | $164.0M | ||
| Q3 24 | $314.4M | $139.4M | ||
| Q2 24 | $325.0M | $128.4M | ||
| Q1 24 | $325.9M | $126.5M |
负债/权益比DLHCRIGL
| Q4 25 | 1.19× | 0.13× | ||
| Q3 25 | 1.13× | 0.51× | ||
| Q2 25 | 1.22× | 0.73× | ||
| Q1 25 | 1.31× | 3.23× | ||
| Q4 24 | 1.46× | 18.25× | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 1.48× | — | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-4.8M | — |
| 自由现金流率自由现金流/营收 | -7.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $29.2M | — |
8季度趋势，按日历期对齐
经营现金流DLHCRIGL
| Q4 25 | $-4.8M | $22.0M | ||
| Q3 25 | $10.7M | $24.0M | ||
| Q2 25 | $9.6M | $30.5M | ||
| Q1 25 | $14.5M | $-893.0K | ||
| Q4 24 | $-11.5M | $14.5M | ||
| Q3 24 | $12.4M | $21.7M | ||
| Q2 24 | $4.6M | $302.0K | ||
| Q1 24 | $5.2M | $-5.0M |
自由现金流DLHCRIGL
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $10.7M | — | ||
| Q2 25 | $9.4M | — | ||
| Q1 25 | $14.0M | — | ||
| Q4 24 | $-12.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $4.5M | — | ||
| Q1 24 | $4.9M | — |
自由现金流率DLHCRIGL
| Q4 25 | -7.0% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 11.2% | — | ||
| Q1 25 | 15.6% | — | ||
| Q4 24 | -13.3% | — | ||
| Q3 24 | 12.7% | — | ||
| Q2 24 | 4.4% | — | ||
| Q1 24 | 4.9% | — |
资本支出强度DLHCRIGL
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.3% | — |
现金转化率DLHCRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 33.12× | 0.51× | ||
| Q1 25 | 16.52× | -0.08× | ||
| Q4 24 | -10.35× | 1.01× | ||
| Q3 24 | 5.42× | 1.75× | ||
| Q2 24 | 4.06× | — | ||
| Q1 24 | 2.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLHC
| Sales Channel Directly To Consumer | $64.5M | 94% |
| Sales Channel Through Intermediary | $4.4M | 6% |
RIGL
暂无分部数据
